Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

Discover how AI tools like AlphaFold and RF Diffusion are revolutionizing protein folding design, medicine, and ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...

Make room for yet another partnership on AI. Current AI, a "public interest" initiative focused on fostering and steering ...

OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...

AI Metascience Fellowship Programme will fund researchers exploring AI's potential to transform scientific research ...